Actively Recruiting
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
Led by First Affiliated Hospital Xi'an Jiaotong University · Updated on 2024-07-12
25000
Participants Needed
1
Research Sites
316 weeks
Total Duration
On this page
Sponsors
F
First Affiliated Hospital Xi'an Jiaotong University
Lead Sponsor
X
Xi'an Gaoxin Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The etiology and specific pathogenesis of many cardiovascular diseases such as coronary atherosclerosis, cardiomyopathy, atrial fibrillation, and stroke are still unclear. Improving diagnosis and treatment, clarifying the pathogenesis, and providing scientific basis for the prevention and treatment are hot research topics in the study of cardiovascular and cerebrovascular diseases. This study intends to collect clinical data and biological specimen data of patients with cardiovascular and cerebrovascular diseases who meet the inclusion and exclusion criteria, and use multi-omics technology to deeply understand the pathogenic mechanisms of cardiovascular and cerebrovascular diseases and provide new ideas for specific and individualized treatment of patients with cardiovascular and cerebrovascular diseases, to construct early predictive prognostic models and provide a basis for effective treatment of clinical practice in patients with cardiovascular and cerebrovascular diseases.
CONDITIONS
Official Title
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who are regularly visited and followed up in the appropriate patient department.
- Patients must meet at least one diagnostic criteria for cardiovascular and cerebrovascular diseases, including coronary artery disease, arrhythmia, heart valve disease, aortic dissection, cardiac masses, myocarditis, hypertension, cardiomyopathy, structural heart disease, ischemic cerebrovascular disease, hemorrhagic cerebrovascular disease, or intracranial space occupying lesion.
You will not qualify if you...
- Age less than 3 years or greater than 80 years.
- Pregnant or lactating women.
- Patients who decline to provide informed consent.
- Patients unable to sign informed consent due to coma or other reasons without a legal representative signing on their behalf, especially if unlikely to regain consciousness.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital of Xian Jiantong University
Xi'an, Shaanxi, China, 710061
Actively Recruiting
Research Team
G
Gouliang Li
CONTACT
Y
Yang Yan
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
12
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here